Lab (Diagnostic Services)

In the field of rheumatology, precise and timely diagnosis is paramount for effective treatment and management of various autoimmune and inflammatory conditions. Ramineni Hospital’s Lab is equipped with cutting-edge technology and staffed by skilled professionals, offering a comprehensive range of diagnostic services tailored to the needs of rheumatology patients. Here’s an overview of the specialized Lab services available for rheumatology at Ramineni Hospital:

• Autoantibody Testing:
  Our Lab conducts autoantibody testing to detect specific antibodies associated with autoimmune rheumatic diseases such as rheumatoid arthritis, systemic lupus erythematosus (SLE), Sjogren’s syndrome, and others. Tests for antinuclear antibodies (ANA), anti-cyclic citrullinated peptide (anti-CCP), rheumatoid factor (RF), and other autoantibodies aid in diagnosing and monitoring these conditions.
• Inflammatory Markers:
  We perform tests to measure inflammatory markers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), which are elevated in many rheumatic diseases. Monitoring these markers helps assess disease activity, guide treatment decisions, and monitor response to therapy.
• Complete Blood Count (CBC):
  CBC testing is routinely performed to assess levels of various blood components, including white blood cells, red blood cells, and platelets. Abnormalities in CBC parameters may indicate underlying conditions such as anemia, infection, or bone marrow disorders, which are common in rheumatology patients.
• Joint Fluid Analysis:
  Our Lab offers joint fluid analysis, including synovial fluid analysis, to evaluate the presence of inflammation, infection, or crystals within the joints. Analysis of joint fluid helps differentiate between various forms of arthritis and assists in guiding treatment decisions.
• Imaging Studies:
  Ramineni Hospital provides advanced imaging services, including X-rays, ultrasound, MRI, and CT scans, to visualize joints, bones, and soft tissues. These imaging modalities aid in diagnosing structural abnormalities, assessing disease progression, and monitoring treatment response in rheumatic conditions.
• Bone Density Testing:
  We offer bone density testing, such as dual-energy X-ray absorptiometry (DEXA) scans, to evaluate bone mineral density and assess the risk of osteoporosis and fractures in rheumatology patients. Early detection and monitoring of osteoporosis are crucial in rheumatic diseases associated with bone loss.
• Genetic Testing:
  Genetic testing may be performed to identify specific genetic markers associated with hereditary rheumatic diseases or to assess genetic predisposition to certain conditions. This information can help in diagnosing and managing familial rheumatic disorders and guiding treatment decisions.